chr8-124475173-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_007218.4(RNF139):c.64C>T(p.Leu22Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,613,654 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_007218.4 missense
Scores
Clinical Significance
Conservation
Publications
- nonpapillary renal cell carcinomaInheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152204Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000521 AC: 13AN: 249730 AF XY: 0.0000296 show subpopulations
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1461334Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727022 show subpopulations
GnomAD4 genome AF: 0.000282 AC: 43AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.000322 AC XY: 24AN XY: 74470 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.64C>T (p.L22F) alteration is located in exon 1 (coding exon 1) of the RNF139 gene. This alteration results from a C to T substitution at nucleotide position 64, causing the leucine (L) at amino acid position 22 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at